Pharma News - Drug Trials News & Articles

961 Pediatric Cardiovascular Drug Dosing in Critically Ill Children and Extracorporeal Membrane Oxygenation Journal of Cardiovascular Pharmacology, March 30, 2011

962 PHOENIX Phase III Trial of PHP for Distributive Shock to Continue after Positive Midpoint Recommendation from DMB B3C newswire, March 29, 2011

963 Abbott to Present Data on Novel Vascular Technologies and XIENCE V at ACC 2011 Abbott, March 29, 2011

964 Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain Alimentary Pharmacology and Therapeutics, March 28, 2011    Clinical Article

965 Prolia(R) (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial Full Text Amgen, March 24, 2011

966 Phase III Clinical Trial of Gilead's Investigational Elvitegravir Meets 48-Week Primary Objective Full Text Gilead, March 24, 2011

967 Southwest Oncology Group study S0413: A phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer Full Text Annals of Oncology, March 23, 2011

968 Improving Clinic Attendance and Adherence to Antiretroviral Therapy Through a Treatment Supporter Intervention in Uganda: A Randomized Controlled Trial AIDS and Behavior, March 23, 2011

969 Preserved Response to Diuretics in Rosiglitazone-Treated Subjects With Insulin Resistance: A Randomized Double-Blind Placebo-Controlled Crossover Study Clinical Pharmacology & Therapeutics, March 23, 2011

970 Monoclonal antibodies for medical oncology: a few critical perspectives Clinical and Translational Oncology, March 23, 2011

971 Cell Therapeutics Initiates Pixantrone PIX-R Pivotal Trial for Treatment of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Full Text Cell Therapeutics, March 22, 2011

972 XenoPort Reports Results from a Phase 2b Clinical Trial of Arbaclofen Placarbil as Adjunctive Treatment for Patients with GERD XenoPort, March 22, 2011

973 Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with 131I-anti-CD20 antibody and stem cell rescue Annals of Hematology, March 17, 2011    Clinical Article

974 Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial Full Text Amylin Pharmaceuticals, March 17, 2011

975 Sucampo and Takeda Initiate Third Phase 3 Clinical Trial of Lubiprostone in Opioid-Induced Bowel Dysfunction Takeda Pharmaceuticals U.S.A., March 17, 2011

976 ACRIN Launches ACRIN 4701 Clinical Trial Imaging Economics, March 17, 2011

977 Second Phase III study of Novartis JAK inhibitor INC424 meets primary endpoint in patients with myelofibrosis Full Text Novartis, March 16, 2011

978 Physician participation in clinical research and trials: issues and approaches Full Text Advances in Medical Education and Practice, March 16, 2011

979 FDA Provides Guidance for Design of Cell Therapeutics' Pixantrone Pivotal Trial Full Text Cell Therapeutics, March 14, 2011

980 Phase I Trial of Weekly and Twice-Weekly Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Relapsed or Refractory non-Hodgkin Lymphoma Full Text Clinical Cancer Research, March 11, 2011    Clinical Article